Mindray Reports Skyrocketing Revenues Despite Global Economic Nosedive
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Mindray Medical International, China's leading medical device maker, posted a sharp rise in revenues for 2008 despite the Western world's financial meltdown, volatile currency fluctuations and a slowdown in spending at some hospitals in the U.S. and across emerging markets, according to Mindray executives
You may also be interested in...
Following Massive Loss Last Year, Chinese CRO WuXi PharmaTech Posts Remarkable Rebound During First Quarter Of 2009
BEIJING - After reporting a devastating $64 million loss for 2008, the leadership of WuXi PharmaTech said that the company had moved back into the black in the first quarter of this year with net income of more than $11 million
Following Massive Loss Last Year, Chinese CRO WuXi PharmaTech Posts Remarkable Rebound During First Quarter Of 2009
BEIJING - After reporting a devastating $64 million loss for 2008, the leadership of WuXi PharmaTech said that the company had moved back into the black in the first quarter of this year with net income of more than $11 million
China’s Mindray Forecasts Beijing’s Health Reforms – Not Obama’s – Will Boost Worldwide Revenues In 2009
BEIJING - Chinese medical device maker Mindray Medical International reported a sharp spike in earnings for 2008, and company leaders forecast that Beijing's ongoing health system reforms will strongly boost revenues this year, despite stagnating or shrinking markets in countries hit hardest by the globe-spanning economic crisis